inflammatory diseases

Lung
Biotech

GSK pens $750M deal for COPD-focused oligonucleotide in phase 1

GSK’s antibody-drug conjugate strategy may be making more headlines recently, but the British pharma hasn’t forgotten about oligonucleotides.
James Waldron Oct 28, 2025 6:45am
An artists concept of T cells attacking a cancer cell The T cells are in red while the cancer is light blue The cells are

Nobel winner turns rogue T cells into their own treatment

Oct 23, 2025 10:35am
two gold elevators opening

British biotech elevates with $70M and midstage arthritis asset

Oct 21, 2025 7:01pm
Nobel Prize medal with background of 100 bills

How Nobel-winning cells could become a 'universal drug'

Oct 21, 2025 2:00pm
Hiking gear with a forest in the background

Expedition resupplies for ph. 2 COPD voyage with $165M series A

Oct 9, 2025 9:50am
Moon Lake

MoonLake stock sinks as high placebo rate eclipses ph. 3 results

Sep 29, 2025 8:05am